Sumaira Irfan, Zahid Mahmood Anjum, Ali Asgher Taseer, Hina Ayesha.
ACUTE SEVERE ASTHMA IN CHILDREN; Role of intravenous magnesium sulfate in treatment.
Professional Med J Jan ;22(8):1039-43.

To compare the efficacy of intravenous magnesium sulfate and conventional treatment with conventional treatment alone in acute severe asthma in children of age group 5 to 15 years known cases of bronchial asthma. Study design: Randomized control trial. Setting: Indoor and outdoor patients of pediatrics department of DHQ hospital, Faisalabad. Duration: Six months. Results: In this study, 43.58%(n=17) in Exposed and 53.85%(n=21) in Un-exposed group were male and remaining 56.42%(n=22) and 46.15%(n=18) were females, mean pulse rate in both groups was recorded which shows 97.32+6.58 in Exposed Group and 103.67+8.32 in Un-exposed Group, p value was calculated as 0.02, mean FEV1 rate in both groups was recorded which shows 60.32+7.56 in Exposed Group and 54.07+6.43 in Un-exposed Group, p value was calculated as 0.03. Conclusion: We concluded that intravenous magnesium sulfate along with conventional treatment is significantly better than conventional treatment alone for the management of acute severe asthma attack.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com